Refine
Has Fulltext
- yes (32)
Is part of the Bibliography
- yes (32)
Year of publication
Document Type
- Journal article (32)
Language
- English (32)
Keywords
- radiotherapy (7)
- prostate cancer (6)
- DNA damage (3)
- IGRT (3)
- hypofractionation (3)
- long-term outcome (3)
- rectal cancer (3)
- toxicity (3)
- DNA repair (2)
- Glioblastoma (2)
- Halcyon (2)
- cancer (2)
- cone beam CT (2)
- image-guided radiation therapy (2)
- radiosensitivity (2)
- radiotherapy (RT) (2)
- salvage radiotherapy (2)
- simultaneous integrated boost (2)
- 4D-MRI (1)
- ATM (1)
- Adaptation (1)
- Akt (1)
- BRAF (1)
- Brain cancer (1)
- CD133 (1)
- CIED malfunction; pacemaker (PM) (1)
- CNS cancer (1)
- Corticosteroids (1)
- DNA double strand breaks (1)
- DNA repair protraction (1)
- DNA-PK (1)
- DNS-Reparatur (1)
- DNS-Schädigung (1)
- Glioma stem cells (1)
- High grade glioma (1)
- IMRT (1)
- IR (1)
- NSCLC (1)
- NVP-BEZ235 (1)
- Nestin (1)
- Non-rigid image registration (1)
- Novel PI3K (1)
- Osteopontin (1)
- PI3K (1)
- PSMA (1)
- PSMA PET/CT (1)
- PTEN (1)
- Peripheral blood lymphocytes (1)
- Prostate carcinoma (1)
- Radiosensitivity (1)
- Radiotherapy (1)
- Radiotherapy treatment planning (1)
- Respiratory induced tumor motion (1)
- Synergy (1)
- TGFβ1 (1)
- Temozolomide (1)
- VMAT (1)
- \(\gamma\)h2ax (1)
- accelerated hyperfractionation (1)
- acute toxicity (1)
- adaptation (1)
- adaptive radiotherapy (1)
- adrenal tumours (1)
- adrenocortical carcinoma (ACC) (1)
- altered fractionation (1)
- apoptosis (1)
- auto-planning (1)
- autophagy (1)
- battery depletion (1)
- biochemical relapse free survival (1)
- blood lymphocytes (1)
- cardiac implantable electronic devices (CIED) (1)
- cardiac resynchronization therapy (CRT) (1)
- chemoradiotherapy (1)
- dabrafenib (1)
- deformable image registration (1)
- dominant intraprostatic lesion (1)
- dose accumulation (1)
- dose escalation (1)
- dose evaluation (1)
- dose to OARs (1)
- double arc (1)
- external beam radiotherapy (EBRT) (1)
- foci (1)
- full arc (1)
- glioblastoma (1)
- head and neck cancer (1)
- head and neck squamous cell carcinoma (1)
- high-dose-rate (HDR) brachytherapy (1)
- high-dose-rate brachytherapy boost (1)
- histone H2AX (1)
- hypoxia (1)
- implantable cardioverter defibrillator (ICD) (1)
- in vivo (1)
- individual radiosensitivity (1)
- intensity-modulated radiation therapy (1)
- intensity-modulated radiotherapy (1)
- irradiation (1)
- local control (1)
- lung cancer (1)
- mTOR Inhibitor (1)
- macroscopic recurrence (1)
- megavoltage computed-tomography (1)
- metastasis-directed therapy (1)
- multimodal therapy (1)
- multiple brain metastases (1)
- neck cancer (1)
- neoadjuvant (1)
- oligorecurrence (1)
- oral mucositis (1)
- osteopontin (1)
- outcomes research (1)
- oxidative DNA damage (1)
- partial arc (1)
- perioperative changes (1)
- peripheral blood lymphocytes (1)
- phosphorylation (1)
- plan comparison (1)
- propensity score matching (1)
- prostate Imaging Reporting and Data System (1)
- radiation (1)
- radiosensibility (1)
- re-irradiation (1)
- re-planning (1)
- repair (1)
- risk (1)
- risk score (1)
- setup verification (1)
- single arc (1)
- strategies (1)
- survival (1)
- temozolomide (1)
- thoracic cancer (1)
- transperineal ultrasound (1)
- treatment plan (1)
- variability (1)
- vemurafenib (1)
- whole breast irradiation (1)
- zinc oxide nanoparticles (1)
Institute
- Klinik und Poliklinik für Strahlentherapie (31)
- Comprehensive Cancer Center Mainfranken (3)
- Klinik und Poliklinik für Nuklearmedizin (3)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (2)
- Medizinische Klinik und Poliklinik I (2)
- Pathologisches Institut (2)
- Theodor-Boveri-Institut für Biowissenschaften (2)
- Frauenklinik und Poliklinik (1)
- Institut für Klinische Epidemiologie und Biometrie (1)
- Institut für Medizinische Strahlenkunde und Zellforschung (1)
Background
The standard clinical protocol of image-guided IMRT for prostate carcinoma introduces isocenter relocation to restore the conformity of the multi-leaf collimator (MLC) segments to the target as seen in the cone-beam CT on the day of treatment. The large interfractional deformations of the clinical target volume (CTV) still require introduction of safety margins which leads to undesirably high rectum toxicity. Here we present further results from the 2-Step IMRT method which generates adaptable prostate IMRT plans using Beam Eye View (BEV) and 3D information.
Methods
Intermediate/high-risk prostate carcinoma cases are treated using Simultaneous Integrated Boost at the Universitätsklinkum Würzburg (UKW). Based on the planning CT a CTV is defined as the prostate and the base of seminal vesicles. The CTV is expanded by 10 mm resulting in the PTV; the posterior margin is limited to 7 mm. The Boost is obtained by expanding the CTV by 5 mm, overlap with rectum is not allowed. Prescription doses to PTV and Boost are 60.1 and 74 Gy respectively given in 33 fractions.
We analyse the geometry of the structures of interest (SOIs): PTV, Boost, and rectum, and generate 2-Step IMRT plans to deliver three fluence steps: conformal to the target SOIs (S0), sparing the rectum (S1), and narrow segments compensating the underdosage in the target SOIs due to the rectum sparing (S2). The width of S2 segments is calculated for every MLC leaf pair based on the target and rectum geometry in the corresponding CT layer to have best target coverage. The resulting segments are then fed into the DMPO optimizer of the Pinnacle treatment planning system for weight optimization and fine-tuning of the form, prior to final dose calculation using the collapsed cone algorithm.
We adapt 2-Step IMRT plans to changed geometry whilst simultaneously preserving the number of initially planned Monitor Units (MU). The adaptation adds three further steps to the previous isocenter relocation: 1) 2-Step generation for the geometry of the day using the relocated isocenter, MU transfer from the planning geometry; 2) Adaptation of the widths of S2 segments to the geometry of the day; 3) Imitation of DMPO fine-tuning for the geometry of the day.
Results and conclusion
We have performed automated 2-Step IMRT adaptation for ten prostate adaptation cases. The adapted plans show statistically significant improvement of the target coverage and of the rectum sparing compared to those plans in which only the isocenter is relocated. The 2-Step IMRT method may become a core of the automated adaptive radiation therapy system at our department.
Background
High expression of constitutive histone γ-H2AX, a sensitive marker of DNA damage, might be indicative of defective DNA repair pathway or genomic instability. 53BP1 (p53-binding protein 1) is a conserved checkpoint protein with properties of a DNA double-strand breaks sensor. This study explores the relationship between the clinical radiosensitivity of tumor patients and the expression/induction of γ-H2AX and 53BP1 in vitro.
Methods
Using immunostaining, we assessed spontaneous and radiation-induced foci of γ-H2AX and 53 BP1 in peripheral blood mononuclear cells derived from unselected breast cancer (BC) patients (n=57) undergoing radiotherapy (RT). Cells from apparently healthy donors (n=12) served as references.
Results
Non-irradiated cells from controls and unselected BC patients exhibited similar baseline levels of DNA damage assessed by γ-H2AX and 53BP1 foci. At the same time, the γ-H2AX assay of in vitro irradiated cells revealed significant differences between the control group and the group of unselected BC patients with respect to the initial (0.5 Gy, 30 min) and residual (2 Gy, 24 h post-radiation) DNA damage. The numbers of 53BP1 foci analyzed in 35 BC patients were significantly higher than in controls only in case of residual DNA damage. A weak correlation was found between residual foci of both proteins tested. In addition, cells from cancer patients with an adverse acute skin reaction (grade 3) to RT showed significantly increased radiation-induced γ-H2AX foci and their protracted disappearance compared to the group of BC patients with normal skin reaction (grade 0–1). The mean number of γ-H2AX foci after 5 clinical fractions was significantly higher than that before RT, especially in clinically radiosensitive patients.
Conclusions
The γ-H2AX assay may have potential for screening individual radiosensitivity of breast cancer patients.